Search | Page 4 | Aplastic Anemia and MDS International Foundation


Search results

  1. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... Associated Drug(s):  Alemtuzumab Azacitidine Fludarabine ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  2. Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

    ... Associated Drug(s):  Alemtuzumab Antithymocyte Globulin ... Intervention:  Drug: Alemtuzumab Alemtuzumab 0.2 mg/kg IV over 2 hours on days -10 to -6 from ...

    Clinical Trial last updated 04/25/2016 - 10:59am.

  3. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Associated Drug(s):  Alemtuzumab Cyclophosphamide Fludarabine ... Other Names: Cytoxan CTX Drug: Alemtuzumab Each dose of alemtuzumab is to be diluted in D5W or NS ...

    Clinical Trial last updated 04/28/2016 - 8:36am.

  4. T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (MOHEL)

    ... Associated Drug(s):  Alemtuzumab Cyclophosphamide ... NS Adults will receive 10mg IV in 100ml NS Other Name: Alemtuzumab Radiation: Total Body Irradiation day-4 through day-1 175 cGy x 2 ...

    Clinical Trial last updated 04/28/2016 - 12:15pm.

  5. Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

    ... Intervention:  Biological: alemtuzumab Conditioning: alemtuzumab 0.2 mg/kg/dose IV x 5 doses Other Name: Campath-1H Drug: ...

    Clinical Trial last updated 04/27/2016 - 8:49am.

  6. Drugs

    ... Name Brand Name alemtuzumab C ampath ...

    Page last updated 03/02/2016 - 9:11am.

  7. Bogdan Dumitriu, MD

    ... Granular Lymphocytes Lymph proliferative Disorders with Alemtuzumab . ...

    Page last updated 04/18/2012 - 1:49pm.